2020 DISCLOSURE OF INTEREST INFORMATION - Global ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2020 DISCLOSURE OF INTEREST INFORMATION
G I N A ADVOCAT ES
Louis-Philippe Boulet, MD Chair of GINA ASIA:
Álvaro A. Cruz, MD Dr Jiangtao Lin China
Chair of GINA D&I Task Group
Dr Le Thi Tuyet Lan Vietnam
Dr Sy Duong-Quy Vietnam
AFRICA:
Dr Yeon Mok Oh South Korea
Dr Agnès Hamzaoui Tunis
Dr Bruce Kirenga Uganda
EUROPE:
Dr Elisabete Nunes Mozambique
Ms Antje F. Wagner Germany
Dr Hisham Tarraf Egypt
Dr Arnaud Bourdin France
Dr Richard van Zyl-Smit South Africa
Ms Dominique Hamerlijnck Netherlands
Dr Ewa Nizankowska Poland
AMERICAS:
Dr Florin Mihaltan Romania
Dr Catherine Lemière Canada
Dr Guy Joos Belgium
Dr Désirée Larenas-Linnemann Mexico
Dr Joaquin Sastre Spain
Dr Francine Ducharme Canada
Ms Mikaela Odemyr Sweeden
Dr Hugo Neffen Argentina
Dr Mina Gaga Greece
Dr Jonathan Bernstein USA
Dr Nicola Scichilone Italy
Dr Jorge Maspero Argentina
Dr Pierluigi Paggiaro Italy
Dr Sateesh M. Sakhamuri
Dr Renaud Louis Belgium
Trinidad & Tobago
Ms Susanna Palkonen Finland
Dr Manuel Soto-Quiros Costa Rica
Dr Tari Haahtela Finland
Dr Michael Wechsler USA
Dr Todor Popov Bulgaria
Dr Rafael Stelmach Brazil
Dr Vibeke Backer Vibeke Dennmark
Dr Richard Leigh Canada
Dr Walter Canonica Italy
Ms Tonya Winders USA
Ms Vanessa Foran Canada
OCEANIA:
Letitia Harding New Zealand
Richard Beasley New Zealand
GL OB AL I NI TIAT IVE F O R A S THM A ( G INA )
D I S CL O SURE OF FIN A NCIA L INTE RE S T
January 1, 2020 - December 31, 2020
Background
The Global Initiative for Asthma (GINA) program is a collaboration between the scientific community and the
private sector. The major objectives are: (1) to increase awareness of asthma among health professionals, health
authorities, and the general public; (2) improve diagnosis, management, and prevention; and (3) stimulate
research. These objectives are being met through preparation of scientific reports on asthma, dissemination and
adoption of recommendations in these reports, and promotion of international collaboration on asthma research.
The purpose of this document is to safeguard the interests of all GINA collaborators by an open disclosure of
interests.
GINA Structure
At present, the GINA program is conducted through a GINA Board of Directors that meets annually (usually in
January), a Scientific Committee and a Dissemination Committee. Each Committee will have an active role in
reviewing and recommending content for GINA documents and all members will be asked to complete this form.
Annual Declaration of Interests
The following declarations are requested by GINA. Please complete the company name select in the
corresponding box whether you have financial relationships (received grants, personal fees, shares, non-financial
support, other). Please include all companies in the bio-medical arena, as well as telehealth/technology, and
tobacco entities. This form will be posted on the GINA website after completion.
Definitions:
1. Grants: refers to any grant paid to your organization.
2. Personal Fees: refers to honorarium, consultation fees, etc for lectures, advisory committees or
consultancy services either intermittent or regular, from which a GINA member benefits personally. This
includes ongoing attendance at advisory board meetings but would not normally include a situation
where an individual is paid for a specific item or for attending or speaking at an occasional meeting.
3. Shares: refers to any shares in asthma-related commercial organizations, excluding unit trusts,
pension plans or mutual funds, and it refers to shares held by a GINA member or family members
(spouse/children). The company is to be listed, not the number of shares.
4. Non-Financial Support: In-kind assistance.
The private sector should not in any way be involved in any aspect of developing documents, including
collecting, reviewing or accessing the literature or determining the content. Once documents have been
produced asthma-related commercial organizations can be involved in their dissemination and audit, including
support for publications.
GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: _Bruce Kirenga_______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
None
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______ ________________________________
th
Date: __18 February 2021___________________
2
GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ________________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
// GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant Personal Non- Other? Nature of
? Fee? Financial involvement:
Support?
Received
speaker
honoraria from
AstraZeneca,
Novartis, MSD,
Boehringer I.,
Speaker honorarium and Pfizers Not regular
Expert Consultation GSK regular
9
pharmaceutical
s
Society Congress funding Non personal Once/year
TOBACCO INDUSTRY FUNDING
// I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature _Hesham Tarraf_____________________________________
1
GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: __Richard van Zyl-Smit ______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Astra Zeneca Yes Honoraria/adboard
Cipla yes Honoraria
Novartis yes Honoraria/adboard
Pfizer yes honoraira
Roche yes Honoraria/adboard
Jannsen yes honoraria
Boehringer Ingelheim yes honoraria
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: ____18 Feb 2021_________________
2
GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ________Catherine Lemiere________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: _____________________
1
GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2021 to Dec 31, 2021
Name: _Désirée Larenas Linnemann
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
XX GINA Assembly
Are there any relevant financial interests to disclose?
Non-
Personal Financial
Name of Entity Grant? Fee? Support? Other? Comments:
Astrazeneca X X Grant for MIA*
Sanofi X Grant for MIA*
Novartis X X Grant for MIA*
GSK X X Grant for MIA*
Mylan/Viatris X X
DBV Technologies X Safety board
Menarini X
Pfizer X
UCB X
Chiesi X
MSD X
Circassia X X
*MIA = manejo integral del asma, mexican guidelines on asthma 2021
TOBACCO INDUSTRY FUNDING
XX I declare that in the last 50 years, I have not received any funding from the tobacco industry and
never shall (!!) or from electronic nicotine delivery system companies that are wholly or partially
owned by tobacco companies
Signature ______________________________________
Date: ___9th March 2021__________________
1
GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2017 to 2022
Name: __Dr. Francine Ducharme______________________________________
Member of (choose one or more):
x GINA Board of Directors
¨ GINA Science Committee
¨ GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non-Financial Other? Nature of
Fee? Support? involvement:
From 2008 - which
issues guidelines on
Canadian Thoracic Society X the diagnosis and
management of
asthma
From 2015 -
Member of Respiratory international group
X
Effectiveness group sharing interests in
research programs
Several granting
agencies and
CIHR and others X
several medical
journals.
Honorarium
Development of a
Thorasys (PUCO) research protocol
$7,588 (2018)
Development of a
Thorasys (REOM) research protocol
$6,668 (2018)
Three continuing
professional
development
Covis Pharma
presentations and a
one-day advisory
$8,599 committee
continuous professional
Abbvie Corporation development
$609.65 presentation
(2019) presentation of
Teva (for Jean Coutu group) a webinar to
$2,000 pharmacists
(2019) continuing
Brunet Pharmacy
$2,229,50 professional
2development
(2019) consultant on
the update of the
Ontario Lung Association pediatric asthma attack
protocol in the
$500 emergency room
(2020) develop a tool
to earn continuing
Fédération des médecins
education credits
spécialistes du Québec
related to the review of
(FMSQ)
article comments or
$1,195,74$ research protocol
(2020) consultant on
GSK
$1,017 severe asthma program
Sanofi $2,844 (2020)Severe asthma
Astrazeneca $400 (2021)
Donations
$5,000 Teva
$1,000 Trudell Medical
Pediatric asthma database
$5,000 Novartis
and Biobank of the CHU
$20,000 GSK
Sainte-Justine
To support the biobank
(2019-2020)
Research grant
Elaboration of
threshold values to
Thorasys/ MedTeq & assess asthma severity
$58,428/$124,769
Mitacs using oscillometry in
children
(2018-2019)
Proof of concept of the
measurement of
pulmonary function by
Thorasys/ MedTeq $61,663/$124,769
the technique of
reverse occlusion.
(2019-2020)
Help Children Breathe
Better Program – to
improve treatment for
the most widespread
chronic childhood
disease in Canada
Bank Scotia Foundation $500,000
Development of pre-
requisites to the
clinical use of
oscillometry in
children
Patient characteristics
and determinants of
GSK $309,000 significant airflow
obstruction in children
with asthma: A
3retrospective cohort
study (FARO)
Research funds to
support investigator
initiated research
project
Research funds to
support investigator
initiated research
project
Comparative efficacy
Covis $186,186 of the use of inhaled
corticosteroids
administered once daily
versus twice daily in
the treatment of
pediatric asthma
TOBACCO INDUSTRY FUNDING
x I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: February 25, 2021
4GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ___________Hugo Eduardo Neffen_____________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly (Advocate)
Are there any relevant financial interests to disclose? NO
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ________ ______________________________
Date: _18/FEB/2020____________________
2GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ____Jonathan A. Bernstein____________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
x GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
PI, consultant,
Novartis x x speaker
PI, consultant,
Genentech x x speaker
Journal of Asthma
Taylor and Francis x Editor in Chief
PI, consultant,
Astra Zeneca x x speaker
PI, consultant,
Sanofi Regeneron x x speaker
GSK x Speaker, Ad board
AAAAI BOD
JTF Member
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: ___2/18/2021__________________
2GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020 Eliminado: _______
Name: JORGE FERNANDO MASPERO MD Eliminado: _
Eliminado: _______¶
Member of (choose one or more): Eliminado: __________
GINA Board of Directors
GINA Science Committee
X GINA Assembly Eliminado:
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
ADVISORY
BOARDS AND
SPEAKER FEES
GRANTS PAID
SANOFI X X X TO INSTITUTION
ADVISORY
BOARDS AND
SPEAKER FEES
GRANTS PAID
ASTRA ZENECA X X X TO INSTITUTION
ADVISORY
BOARDS AND
SPEAKER FEES
GRANTS PAID
NOVARTIS X X X TO INSTITUTION
ADVISORY
BOARDS AND
SPEAKER FEES
GRANTS PAID
MSD X X TO INSTITUTION
ADVISORY
BOARDS FEES ,
GRANTS PAID
GSK X X TO INSTITUTION
URIACH X SPEAKER FEES
ADVISORY
BOARDS AND
SPEAKER FEES
INMUNOTEK X X
GRANTS PAID
LILLY X TO INSTITUTION
2Eliminado:
TEVA X X SPEAKER FEES
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from Eliminado:
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Eliminado: __________
Signature JORGE FERNANDO MASPERO MD, FAAAAI, FCCP
Date: _________FEBRUARY 22 , 2021 ____________
3GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: Dr. Sateesh Sakhamuri ________________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
Are there any relevant financial interests to disclose? No
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Nil Nil Nil Nil Nil Not applicable
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ___
Date: 17/02/2021____________________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: _____Michael Wechsler___________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
AstraZeneca x x Investigator/consultant
Genentech x consultant
Novartis x consultant
Sanofi x x Investigator/consultant
regeneron x consultant
Genzyme x consultant
Boehringer INgelheim x x consultant
Cohero x x Consultant/investigator
Sentien x consultant
Glaxosmithkline x consultant
TOBACCO INDUSTRY FUNDING
x I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: __Richard Leigh______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Clinical trials (paid
to University);
consulting and
AstraZeneca, speakers’ fees
Clinical trials (paid
to University);
consulting and
GlaxoSmithKline, speakers’ fees
Clinical trials (paid
Novartis to University)
Clinical trials (paid
to University);
Genzyme Sanofi speakers’ fees
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ____ __________________________________
Date: __18 February 2021___________________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ______Tonya Winders__________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of involvement:
Fee? Financial
Support?
GAAPP & AAN received
funding for unbranded disease
education and awareness. I
personally received funds as a
PRECISION advisor and speaker
AstraZeneca Yes Yes No No for unbranded programs.
GAAPP & AAN received
funding for unbranded disease
education and awareness.
GAAPP also received in-kind
donation of agency support for
GSK Yes No Yes No web content & SEO.
GAAPP & AAN received
funding for unbranded disease
education and awareness. I
personally received funds as an
advisor and speaker for
Sanofi/Regeneron Yes Yes No No unbranded programs.
GAAPP & AAN received
funding for unbranded disease
Novartis Yes No No No education and awareness.
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ________ ______________________________
Date: ____18 Feb 2021_________________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: Le Thi Tuyet Lan
Member of (choose one or more):
☐GINA Board of Directors
☐ GINA Science Committee
☒ GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Honoraria,
AstraZeneca Yes Yes No No Consultation fee
No Yes No No
Boehringer Ingelheim Honoraria
Yes Yes No No Honoraria,
GlaxoSmithKline Consultation fee
Yes Yes No No Honoraria,
Novartis Research Fund
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature
Date: 19th Feb 2021
2GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: Yeon-Mok Oh
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
GSK KOREA No Yes No No honorarium
Boehringer Ingelheim No Yes No No honorarium
Norvatis Korea No Yes No No honorarium
Boehringer Ingelheim
Korea No Yes No No honorarium
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ____ __________________________________
Date: __18 Feb. 2021___________________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2021 _______ to _Dec 31, 2021_______
Name: ___Arnaud Bourdin
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
x GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Investigator for
Sanofi Regeneron X x x clinical trials
Investigator for
GSK x x x x clinical trials
Investigator for
Astra Zeneca x x x x clinical trials
Investigator for
Novartis x x x clinical trials
Investigator for
Boeringher Ingelheim x x x clinical trials
Investigator for
Chiesi x x x clinical trials
Investigator for
Vertex x clinical trials
Investigator for
Actelion x x x clinical trials
Investigator for
Galapagos x clinical trials
Investigator for
Acceleron x clinical trials
TOBACCO INDUSTRY FUNDING
2x I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature _ _____________________________________
Date: _____22 feb 2021________________
3GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: __Dominique Hamerlijnck______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
X GINA Advocate
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Member of patient
NOVARTIS X advisory board
Member of patient
CHIESI X advisory board
Member of
ZONMW X advisory committees
European Respiratory
Society X Co-chair CRC
Member of
UMCU X advisory board
Member of patient
EFP/EUPATI X advisory board
Member od patient
Rising Tides X advisory board
Member scientific
EIT Health X advisory board
Pharmerit X Lecturer
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
2Signature ____ __________________________________
Date: ___18-2-2021__________________
3GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: Prof Ewa Niżankowska-Mogilnicka
Member of (choose one or more):
¨ GINA Board of Directors
¨ GINA Science Committee
¨ GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
No No No No No No
TOBACCO INDUSTRY FUNDING
¨ I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: 18.02.2021
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 _______ to _Dec 31, 2020_______
Name: JOAQUIN SASTRE
Member of (choose one or more):
¨ GINA Board of Directors
¨ GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Grant, speaker,
SANOFI X X advisory
GSK X Advisory, speaker
Mundipharma X Speaker
FAES FARMA X Speaker
MERK Co X Speaker, advisory
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: February 19, 2021
2GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: _Mikaela Odemyr, EFA President_______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
✓ GINA Advocates
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Unrestricted grants
Aimmune ✓ to EFA
Unrestricted grant to
Astra Zeneca ✓ EFA
Unrestricted grant to
Boehringer Ingelheim ✓ EFA
Unrestricted grant
DBV Technologies ✓ to EFA
Unrestricted grant to
GSK ✓ EFA
Unrestricted grant to
LEO Pharma ✓ EFA
Unrestricted grant to
Novartis ✓ EFA
Unrestricted grant
Pfizer ✓ to EFA
Unrestricted grant to
Regeneron ✓ EFA
Unrestricted grant
Sanofi ✓ to EFA
Asthma Patient
Advisory
Committee,
Novartis ✓ honoraria to EFA
Global Respiratory
Patient Advisory
Committee
GSK ✓ honoraria to EFAParticipation in
precision medicine
Astra Zeneca ✓ events
TOBACCO INDUSTRY FUNDING
✓ I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by
tobacco companies
Signature ______________________________________
Date: __05/03/2021___________________
3GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: Pierluigi Paggiaro, Italy
Member of (choose one or more):
¨ GINA Board of Directors
¨ GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Institutional
AstraZeneca X support to research
Chiesi X ibidem
Ibidem + grants for
educational
activities and
Sanofi X X advisory boards
grants for
educational
activities and
GlaxoSmithKline X advisory boards
grants for
educational
activities and
Novartis X advisory boards
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companiesSignature
Date: _april 23rd 2021
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ________________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose? NONE
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ____ __________________________________
Date: _____________________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ________________________________________
Member of (choose one or more):
¨ GINA Board of Directors
¨ GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
NATIONAL ADVISORY
ASTRA ZENECA X BOARD
SUPPORT TO
RESEARCH ACTIVITIES;
NATIONAL ADVISORY
CHIESI X X BOARD
SUPPORT TO
RESEARCH ACTIVITIES;
NATIONAL ADVISORY
GSK X X BOARD
SUPPORT TO
SANOFI X RESEARCH ACTIVITIES
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ______________________________________
Date: FEBRUARY 25, 2021
2GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: __LOUIS Renaud______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
GSK X X
AZ X X
Chiesi X
Novartis X
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ________Renaud LOUIS______________________________
Date: ________19/2/2021_____________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: _Susanna Palkonen, EFA Director_______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
GINA Assembly
✓ GINA Advocates
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Unrestricted grants
Aimmune ✓ to EFA
Unrestricted grant to
Astra Zeneca ✓ EFA
Unrestricted grant to
Boehringer Ingelheim ✓ EFA
Unrestricted grant
DBV Technologies ✓ to EFA
Unrestricted grant to
GSK ✓ EFA
Unrestricted grant to
LEO Pharma ✓ EFA
Unrestricted grant to
Novartis ✓ EFA
Unrestricted grant
Pfizer ✓ to EFA
Unrestricted grant to
Regeneron ✓ EFA
Unrestricted grant
Sanofi ✓ to EFA
European Patient
Advisory
Committee,
European Patient
Innovation Summit
Steering Committee,
Novartis ✓ honoraria to EFA
European Health
Advisory Board,
GSK ✓ honoraria to EFA
2Global COPD
Global Policy
Steering Committee
Astra Zeneca ✓ honoraria to EFA
Respiratory
Taskforce Advisory
Astra Zeneca Group no honoraria
Severe Asthma
Working Group
Sanofi-Regeneron Alliance ✓ honoraria to EFA
TOBACCO INDUSTRY FUNDING
✓ I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by
tobacco companies
Signature ______________________________________
Date: __05/03/2021___________________
3GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: _Vibeke Backer_______________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
x
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
TOBACCO INDUSTRY FUNDING
I declare that in the last 5 years, I have not received any funding from the tobacco industry or
from electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature _Vibeke Backer_____________________________________
Date: ___18.02.2021__________________
1GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020 Eliminato: _
Name: _Giorgio Walter Canonica_______________________________________ Eliminato: _
Eliminato: _
Member of (choose one or more):
¨ GINA Board of Directors
¨ GINA Science Committee
X GINA Assembly …Advocate Eliminato: ¨
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
Sanofi Genzyme X X
Novartis X X
Chiesi X X
GSK X X
AstraZeneca X X
Menarini X
Stallergenes-Greer X X
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from Eliminato: ¨
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature __ ____________________________________
2GLOBAL INITIATIVE FOR ASTHMA (GINA)
DISCLOSURE OF INTEREST
FOR THE PERIOD Jan 1, 2020 to Dec 31, 2020
Name: ____Richard Beasley____________________________________
Member of (choose one or more):
GINA Board of Directors
GINA Science Committee
X GINA Assembly
Are there any relevant financial interests to disclose?
Name of Entity Grant? Personal Non- Other? Nature of
Fee? Financial involvement:
Support?
AstraZeneca Yes Yes
GlaxoSmithKline No Yes
Cipla No Yes
Fisher and Paykel
HealthCare Yes No
Genentech Yes No
TOBACCO INDUSTRY FUNDING
X I declare that in the last 5 years, I have not received any funding from the tobacco industry or from
electronic nicotine delivery system companies that are wholly or partially owned by tobacco
companies
Signature ___ ___________________________________
1You can also read
